CapsoVision Inc
CV
View Detailed Chart
12.610USD
-0.290-2.25%
Market hours （ET）Quotes delayed by 15 min
590.13MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.25%
5 Days
+5.08%
1 Month
+141.11%
6 Months
0.00%
Year to Date
0.00%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score of CapsoVision Inc
Currency: USD Updated: 2025-12-23Key Insights
CapsoVision Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 86/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is relatively high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CapsoVision Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
6.000
Target Price
-17.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
CapsoVision Inc Highlights
StrengthsRisks
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Growing
The company is in a growing phase, with the latest annual income totaling USD 11.76M.
Undervalued
The company’s latest PE is -11.21, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 196.14K shares, increasing 46.61% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 562.00 shares of this stock.
CapsoVision Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
CapsoVision Inc Info
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Ticker SymbolCV
CompanyCapsoVision Inc
CEOWang (Kang-Huai)
Websitehttps://www.capsovision.com/
FAQs
What is the current price of CapsoVision Inc (CV)?
The current price of CapsoVision Inc (CV) is 12.610.
What is the symbol of CapsoVision Inc?
The ticker symbol of CapsoVision Inc is CV.
What is the 52-week high of CapsoVision Inc?
The 52-week high of CapsoVision Inc is 6.970.
What is the 52-week low of CapsoVision Inc?
The 52-week low of CapsoVision Inc is 3.434.
What is the market capitalization of CapsoVision Inc?
The market capitalization of CapsoVision Inc is 590.13M.
What is the net income of CapsoVision Inc?
The net income of CapsoVision Inc is -19.90M.
Is CapsoVision Inc (CV) currently rated as Buy, Hold, or Sell?
According to analysts, CapsoVision Inc (CV) has an overall rating of Buy, with a price target of 6.000.
What is the Earnings Per Share (EPS TTM) of CapsoVision Inc (CV)?
The Earnings Per Share (EPS TTM) of CapsoVision Inc (CV) is -1.151.
Related Instruments
+0.52%
-0.37%
+0.16%
-0.29%
-0.46%
-0.43%
+0.02%
-0.33%
-0.36%
+0.79%
+0.15%
-0.04%
+0.68%
+0.18%
-0.11%
-0.00%
+0.01%
-0.30%
-0.08%
-0.60%Popular Symbols
